SAN FRANCISCO, November 30, 2016 /PRNewswire/ --
The global coagulation analyzers/reagents market is expectedto reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.
Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:
Browse full research report with TOC on "Coagulation Analyzer Market Analysis By Product, By Technology (Mechanical, Electrochemical) By Test Types (APTT, D-Dimer, Fibrinogen, PT) By End Use (Hospitals, Research Institutes) & Segment Forecasts, 2013 - 2024" at: http://www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market
Further key findings from the study suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global Coagulation Analyzers & Reagents market on the basis of product, technology, test type, end-use and region.
Access research insight: http://www.grandviewresearch.com/research-insights/coagulation-analyzers-reagents-faster-diagnosis
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - http://www.grandviewresearch.com/blogs/healthcare
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All